The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Podcasts
Get the basics on what healthcare supply chain and manufacturers, together with clinical and IT departments, must do to implement the Unique Device
Podcasts
A value analysis process to verify the achievement of the outcomes desired will result in making decisions based on the data, celebrating achieveme
On-Demand Educational Webinars
This session is a comprehensive approach to understanding Lean Management System concepts, processes, tools, and their application to improving…
On-Demand Educational Webinars
Health care costs continue to rise at an alarming rate, growing well ahead of inflation. In this webinar, we compare and contrast the education and…
On-Demand Educational Webinars
As hospitals restructure to gain sustainability in an era of reform, it is crucial for supply chain leaders to work collaboratively within health…